Evidence map›Paper›PMID 37300007›Full record

ArticleSensors (Basel, Switzerland)2023

Titanium Nitride Modified Fiber Optic Interferometer for Refractive Index Sensitivity Enhancement.

Duo Yi, Bin Zhang, Youfu Geng, Xuejin Li

Abstract read
In one paragraph

Article in Sensors (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Duo YiCollege of Physics and Optoelectronic Engineering, Shenzhen University, Shenzhen 518060, China.
Bin ZhangInstitute of Translational Medicine, The First Affiliated Hospital (Shenzhen Second People's Hospital), Shenzhen University, Health Science Center, Shenzhen 518060, China.ORCID 0000-0002-2112-2555
Youfu GengCollege of Physics and Optoelectronic Engineering, Shenzhen University, Shenzhen 518060, China.ORCID 0000-0002-0019-3813
Xuejin LiSchool of Science, Chinese University of Hong Kong, Shenzhen 518172, China.

Funding

National Natural Science Foundation of China 51808347Shenzhen Basic Research Project JCYJ20220531103007016Stabilization Support Program for Higher Education Institutions of Shenzhen 20200811232156001The Basic and Applied Research Foundation of Guangdong Province 2020A1515010787, 2020A1515110749
6 · The paper itself

Abstract

As one of the most well-established biocompatible transition metal nitrides, titanium nitride (TiN) has been widely applied for fiber waveguide coupling device applications. This study proposes a TiN-modified fiber optic interferometer. Benefiting from the unique properties of TiN, including ultrathin nanolayer, high refractive index, and broad-spectrum optical absorption, the refractive index (RI) response of the interferometer is greatly enhanced, which is desired all the time in the field of biosensing. The experimental results show that the deposited TiN nanoparticles (NPs) can enhance the evanescent field excitation and modulate the effective RI difference of the interferometer, which eventually results in the RI response enhancement. Besides, after incorporating the TiN with different concentrations, the resonant wavelength and the RI responses of the interferometer are enhanced to varying degrees. Benefitting from this advantage, the sensing performances, including sensitivity and measurement range, can be flexibly adapted based on different detection requirements. Since RI response can effectively reflect the detection ability of biosensors, the proposed TiN-sensitized fiber optic interferometer can be potentially applied for high-sensitive biosensing applications.

Indexed as

RefractometryTinFiber Optic TechnologyInterferometryTitaniumTinTitaniumtitanium nitridefiber optic interferometerrefractive index enhancementtitanium nitride

Identifiers

PMID37300007
PMCPMC10256003

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.